Morphic Holding Inc (MORF): Eigentümerstruktur Nicht notiert
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Morphic Holding Inc
Mitarbeiter 128
Handelsplatz NASDAQ
Ticker Symbol MORF
IPO Datum 2019-06-27
Adresse 35 Gatehouse Drive, A2, Waltham, MA, United States, 02451
Webseite https://www.morphictx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Praveen P. Tipirneni M.B.A., M.D. | CEO, MD & Director |
| 2 | Dr. Bruce N. Rogers Ph.D. | President |
| 3 | Dr. Timothy A. Springer M.B.A., Ph.D. | Founder, Independent Director & Member of Scientific Advisory Board |
| 4 | Dr. Marc Schegerin M.B.A., M.D. | CFO & COO |
| 5 | Mr. Robert E. Farrell Jr., CPA | Senior VP of Finance & Chief Accounting Officer |
| 6 | Dr. Blaise Lippa Ph.D. | Chief Scientific Officer |
| 7 | Mr. William D. DeVaul Esq. | General Counsel & Secretary |
| 8 | Mr. Aaron Pelta | Senior Vice President of Business & Corporate Development |
| 9 | Ms. Joanne Gibbons | Senior Vice President of Regulatory Affairs |
| 10 | Dr. Simon Cooper MBBS | Chief Medical Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 14,96% | 0,43 Mrd. USD |
| 2 | Wellington Management Company LLP | 11,58% | 0,33 Mrd. USD |
| 3 | EcoR1 Capital, LLC | 9,92% | 0,28 Mrd. USD |
| 4 | BlackRock Inc | 7,02% | 0,20 Mrd. USD |
| 5 | Artal Group S A | 5,03% | 0,14 Mrd. USD |
| 6 | Vanguard Group Inc | 4,41% | 0,13 Mrd. USD |
| 7 | T. Rowe Price Associates, Inc. | 4,39% | 0,13 Mrd. USD |
| 8 | Woodline Partners LP | 3,55% | 0,10 Mrd. USD |
| 9 | State Street Corp | 3,26% | 0,09 Mrd. USD |
| 10 | Point72 Asset Management, L.P. | 2,91% | 0,08 Mrd. USD |
| 11 | Pictet Asset Manangement SA | 2,03% | 0,06 Mrd. USD |
| 12 | Federated Hermes Inc | 1,98% | 0,06 Mrd. USD |
| 13 | Geode Capital Management, LLC | 1,93% | 0,06 Mrd. USD |
| 14 | Goldman Sachs Group Inc | 1,26% | 0,04 Mrd. USD |
| 15 | Orbimed Advisors, LLC | 1,22% | 0,04 Mrd. USD |
| 16 | SILVERARC CAPITAL MANAGEMENT, LLC | 0,97% | 0,03 Mrd. USD |
| 17 | Two Sigma Advisers, LLC | 0,80% | 0,02 Mrd. USD |
| 18 | Novo A/S | 0,75% | 0,02 Mrd. USD |
| 19 | MPM Oncology Impact Management LP | 0,74% | 0,02 Mrd. USD |
| 20 | Northern Trust Corp | 0,68% | 0,02 Mrd. USD |